Fosun Pharma (02196.HK) holding company Complex Polyethylene Glycol (3350) Electrolyte Dispersant's drug registration application has been accepted by the National Medical Products Administration.

Zhitong Finance APP News, Fosun Pharma (02196.HK) announced that Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (hereinafter referred to as "the Company")'s subsidiary Shanghai Chaohui Pharmaceutical Co., Ltd. has recently had its drug registration application for compound polyethylene glycol (3350) electrolyte dispersing agent (hereinafter referred to as "the drug") accepted by the National Medical Products Administration.